A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practi...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f07 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bfd8079fb50d43aa817d5b60a0157f07 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bfd8079fb50d43aa817d5b60a0157f072021-11-14T04:30:48ZA naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review0965-229910.1016/j.ctim.2021.102788https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f072021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0965229921001291https://doaj.org/toc/0965-2299Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practice for mild and moderate COVID-19. Design: A retrospective chart review was conducted of 30 consecutive patients diagnosed with mild and moderate COVID-19 who were provided multi-nutrient, herbal, and probiotic treatment in a rural, out-patient, naturopathic primary care setting. Main outcomes measures: The primary outcome was treatment safety; secondary outcomes included changes in symptoms, progression to severe COVID-19, incidence of long COVID, and recovery time. Results: No side effects or adverse events were reported from treatment and all patients experienced resolution of symptoms presumed to be associated with COVID-19 infection. One patient who had been ill for 28 days prior to presentation was hospitalized. Five patients had an illness duration of more than one month. Time to treatment was correlated with duration of illness post-treatment (r = 0.63, p < 0.001) and more symptoms at presentation was correlated with a longer duration of illness (r = 0.52, p < 0.01). Conclusions: In this retrospective chart review, a multi-nutrient, herbal, and probiotic therapeutic approach for mild and moderate COVID-19 appeared to be well-tolerated. Delay in seeking treatment after symptom onset, as well as more symptoms at presentation, were correlated with a longer duration of illness. This treatment strategy may have clinical benefit, warranting prospective clinical trials with confirmed COVID-19 cases.Melissa S. BarberRichard BarrettRyan D. BradleyErin WalkerElsevierarticleCOVID-19SARS-CoV-2Herbal medicinePhytotherapyVitaminsMineralsOther systems of medicineRZ201-999ENComplementary Therapies in Medicine, Vol 63, Iss , Pp 102788- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
COVID-19 SARS-CoV-2 Herbal medicine Phytotherapy Vitamins Minerals Other systems of medicine RZ201-999 |
spellingShingle |
COVID-19 SARS-CoV-2 Herbal medicine Phytotherapy Vitamins Minerals Other systems of medicine RZ201-999 Melissa S. Barber Richard Barrett Ryan D. Bradley Erin Walker A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
description |
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practice for mild and moderate COVID-19. Design: A retrospective chart review was conducted of 30 consecutive patients diagnosed with mild and moderate COVID-19 who were provided multi-nutrient, herbal, and probiotic treatment in a rural, out-patient, naturopathic primary care setting. Main outcomes measures: The primary outcome was treatment safety; secondary outcomes included changes in symptoms, progression to severe COVID-19, incidence of long COVID, and recovery time. Results: No side effects or adverse events were reported from treatment and all patients experienced resolution of symptoms presumed to be associated with COVID-19 infection. One patient who had been ill for 28 days prior to presentation was hospitalized. Five patients had an illness duration of more than one month. Time to treatment was correlated with duration of illness post-treatment (r = 0.63, p < 0.001) and more symptoms at presentation was correlated with a longer duration of illness (r = 0.52, p < 0.01). Conclusions: In this retrospective chart review, a multi-nutrient, herbal, and probiotic therapeutic approach for mild and moderate COVID-19 appeared to be well-tolerated. Delay in seeking treatment after symptom onset, as well as more symptoms at presentation, were correlated with a longer duration of illness. This treatment strategy may have clinical benefit, warranting prospective clinical trials with confirmed COVID-19 cases. |
format |
article |
author |
Melissa S. Barber Richard Barrett Ryan D. Bradley Erin Walker |
author_facet |
Melissa S. Barber Richard Barrett Ryan D. Bradley Erin Walker |
author_sort |
Melissa S. Barber |
title |
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
title_short |
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
title_full |
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
title_fullStr |
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
title_full_unstemmed |
A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review |
title_sort |
naturopathic treatment approach for mild and moderate covid-19: a retrospective chart review |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/bfd8079fb50d43aa817d5b60a0157f07 |
work_keys_str_mv |
AT melissasbarber anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT richardbarrett anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT ryandbradley anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT erinwalker anaturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT melissasbarber naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT richardbarrett naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT ryandbradley naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview AT erinwalker naturopathictreatmentapproachformildandmoderatecovid19aretrospectivechartreview |
_version_ |
1718429983466061824 |